However, it is worth mentioning that the occurrence of mutations in TP53 and RB1, which are crucial oncogenes for the initiation of SCLC, was comparatively lower than what was observed in George's study (TP53:100% versus 72%; RB1: 90% versus 56%). Here, TP53 is linked to small cell lung carcinoma.